Activists Protest Novartis Challenge To Indian Patent Law
In this guest post in the Center for Global Health Policy's "Science Speaks" blog, Brook Baker of the Northeastern University School of Law Program on Human Rights and the Global Economy, "describe[s] and comment[s] on pharmaceutical company Novartis's court challenge to India's strict standards of patenting medicine" and worldwide protests against the company that took place last week prior to its shareholder meeting (Mazzotta, 2/27).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.